Biotech news for Tuesday, June 30, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
Andy Andrews Zymeworks ( ZYME ) said it will acquire Theravance Biopharma ( TBPH ) in an all-cash deal valued at about $929M, paying $17 per share, to expand its commercial portfolio with chronic obstructive pulmonary disease (( COPD)) treatment YUPELRI. YUPEL…
Viridian Therapeutics ( VRDN ) on Saturday launched its first commercial product, Lumvoa, soon after the U.S. FDA approved the intravenous therapy for thyroid eye disease, a rare autoimmune disease characterized by ocular symptoms such as bulging eyes. The app…
kmk-vova/iStock via Getty Images The US FDA has approved AbbVie's Skyrizi (risankizumab) for use in children six years and older with moderate-to-severe plaque psoriasis or active psoriatic arthritis. Approval was based on results from the phase 3 OptIMMize ps…
Matinas BioPharma ( MTNB ) announced on Friday that it received a notice from NYSE American for not meeting the exchange's minimum shareholder equity requirement. The company's shareholder equity fell to $3.02M in March 2026, below the required $4M threshold a…
Ascendis Pharma ( ASND ) said on Friday it was added to the Russell 3000, Russell 1000, Russell 2500 and Russell Midcap indexes as part of the 2026 Russell U.S. Indexes annual reconstitution, effective after the close of trading on June 26.
Jonathan Kitchen The Nasdaq ( COMP:IND ) fell around 4.50%, snapping its two-week winning streak as the technology sector extended its selloff amid growing concerns over elevated AI-related valuations and reports that OpenAI is considering delaying its IPO unt…
greenleaf123 Ardelyx ( ARDX ) shares fell ~6% on Friday after the company lost an appeal against the Health and Human Services Department regarding a Medicare decision that eliminated Part D coverage for its kidney disease therapy, Xphozah. The lawsuit filed i…
Veronique D Moderna ( MRNA ) shares surged nearly ~15% on Friday to around ~$69 and are now up almost ~42% over the past month. The stock has also crushed the S&P 500 ( SP500 )'s return of ~7.49%, delivering gains of more than ~114% over the
meshaphoto/E+ via Getty Images Healthcare was a notable outperformer on Wall Street on Friday as several top sector components of the S&P 500 ( SP500 ), including Eli Lilly ( LLY ), Johnson & Johnson ( JNJ ), and AbbVie ( ABBV ), recorded all-time high…